Leo Creative

  • Home
  • About
  • Our Approach
  • Our Work
    • Branding
    • Healthcare
  • Contact

Launching a new treatment for Dupuytren’s contracture

Client: Janssen Australia

dupuytens

Leo Creative worked with Janssen on the Australian launch of collagenase – a non-surgical TGA approved treatment for Dupuytren’s contracture. Like most pharma branding, the creative was done overseas, so the task was to adapt global brand assets for the local Australia market.

A wide range of collateral was produced including mandatory items like product information and consumer medicine information, printed detail aid and e-detailer (Veeva iRep), physician and patient guides.

Filed Under: work

Clinical Genomics capital raising

Client: Clinical Genomics Technologies Pty Ltd CGT was formed in 2006 to discover and deliver healthcare products that address the unmet needs of large healthcare markets. The company sells stool … MORE

PAH Clinic: Speaker Tour Issue

Client: Janssen Australia When Janssen Australia sponsored a world-renowned Pulmonary Arterial Hypertension (PAH) expert to visit Australia, Leo Creative was commissioned to design a range of … MORE

A new brand story for Barker College

An audit of Barker College’s advertising and a review of quant and qual research led to a new brand story for Barker College. Following the successful delivery of a new enrolment prospectus, Barker … MORE

The role of branding in highly specialised markets

In our post “What we believe about pharma branding”, we gave a brief overview of the history of branding and the adoption of the FMCG branding model by big pharma where value is driven by the … MORE

Copyright © 2025 Leo Creative Pty Ltd · Genesis Framework by StudioPress · Log in